These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25205635)

  • 1. Reply to Wang and Liang.
    Ross AG; Li Y
    J Infect Dis; 2015 Mar; 211(5):849-50. PubMed ID: 25205635
    [No Abstract]   [Full Text] [Related]  

  • 2. Mass drug administration (MDA) for schistosomiasis.
    Wang W; Liang Y
    J Infect Dis; 2015 Mar; 211(5):848-9. PubMed ID: 25205633
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progress of research on preparation and application of praziquantel].
    Wu DZ; Ma Z; Liu YF; Zhu WF; Ning A
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Apr; 25(2):194-6. PubMed ID: 23894845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global trends in schistosomiasis control.
    Taylor M
    Bull World Health Organ; 2008 Oct; 86(10):738. PubMed ID: 18949203
    [No Abstract]   [Full Text] [Related]  

  • 5. An achievable goal: control and elimination of schistosomiasis.
    Savioli L; Fenwick A; Rollinson D; Albonico M; Ame SM
    Lancet; 2015 Aug; 386(9995):739. PubMed ID: 26333971
    [No Abstract]   [Full Text] [Related]  

  • 6. Tackling neglect: treating schistosomiasis in pregnancy.
    Luty AJ; Elliott AM
    Lancet Infect Dis; 2016 Feb; 16(2):137-9. PubMed ID: 26511958
    [No Abstract]   [Full Text] [Related]  

  • 7. Triple drug administration (TDA), with praziquantel, ivermectin and albendazole, for the prevention of three neglected tropical diseases in Nigeria.
    Eigege A; Pede E; Miri E; Umaru J; Ogbu Pearce P; Jinadu MY; Njepuome AN
    Ann Trop Med Parasitol; 2008 Mar; 102(2):177-9. PubMed ID: 18318940
    [No Abstract]   [Full Text] [Related]  

  • 8. Decades down the line: the viability of praziquantel for future schistosomiasis treatment.
    Cioli D; Basso A; Valle C; Pica-Mattoccia L
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):835-7. PubMed ID: 23030319
    [No Abstract]   [Full Text] [Related]  

  • 9. An audacious goal: the elimination of schistosomiasis in our lifetime through mass drug administration.
    Ross AG; Olveda RM; Li Y
    Lancet; 2015 May; 385(9983):2220-1. PubMed ID: 25467574
    [No Abstract]   [Full Text] [Related]  

  • 10. Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis.
    Stothard JR; Sousa-Figueiredo JC; Navaratnam AM
    Expert Rev Anti Infect Ther; 2013 Jul; 11(7):733-52. PubMed ID: 23879611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can mass drug administration lead to the sustainable control of schistosomiasis?
    Ross AG; Olveda RM; Chy D; Olveda DU; Li Y; Harn DA; Gray DJ; McManus DP; Tallo V; Chau TN; Williams GM
    J Infect Dis; 2015 Jan; 211(2):283-9. PubMed ID: 25070942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda.
    Chami GF; Kontoleon AA; Bulte E; Fenwick A; Kabatereine NB; Tukahebwa EM; Dunne DW
    Clin Infect Dis; 2016 Jan; 62(2):200-7. PubMed ID: 26409064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulvar lesion in a 45-year-old woman.
    Fraysse-Consigny S; Chosidow O; Becherel PA; Datry A; Frances C
    Arch Dermatol; 2002 Sep; 138(9):1245-50. PubMed ID: 12224993
    [No Abstract]   [Full Text] [Related]  

  • 14. Field test of the 'dose pole' for praziquantel in Zanzibar.
    Montresor A; Engels D; Ramsan M; Foum A; Savioli L
    Trans R Soc Trop Med Hyg; 2002; 96(3):323-4. PubMed ID: 12174788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [One case of acute kidney injury caused by praziquantel].
    Chai ZW; Xu QC
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Apr; 23(2):228. PubMed ID: 22164638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inclusive dose pole for treatment of schistosomiasis in infants and preschool children with praziquantel.
    Sousa-Figueiredo JC; Day M; Betson M; Kabatereine NB; Stothard JR
    Trans R Soc Trop Med Hyg; 2010 Nov; 104(11):740-2. PubMed ID: 20832093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostics for schistosomiasis in Africa and Arabia: a review of present options in control and future needs for elimination.
    Stothard JR; Stanton MC; Bustinduy AL; Sousa-Figueiredo JC; Van Dam GJ; Betson M; Waterhouse D; Ward S; Allan F; Hassan AA; Al-Helal MA; Memish ZA; Rollinson D
    Parasitology; 2014 Dec; 141(14):1947-61. PubMed ID: 25158604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mazzotti reaction after presumptive treatment for schistosomiasis and strongyloidiasis in a Liberian refugee.
    Olson BG; Domachowske JB
    Pediatr Infect Dis J; 2006 May; 25(5):466-8. PubMed ID: 16645520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Height as a substitute for weight for estimating praziquantel dosage.
    Idowu ET; Mafe MA; Appelt B; Adewale B; Adeneye AK; Akinwale OP; Manafa OU; Akande DO
    World Health Popul; 2007; 9(3):19-26. PubMed ID: 18272939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical dosing of praziquantel for schistosomiasis in preschool-aged children.
    Olliaro PL; Vaillant M; Hayes DJ; Montresor A; Chitsulo L
    Trop Med Int Health; 2013 Sep; 18(9):1085-1089. PubMed ID: 23937700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.